LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer

Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2013
This article has no abstract
Epistemonikos ID: 15d8fe34e28f8c5481272dd2c7741ac55917b2ad
First added on: Apr 16, 2025